Early exposure, Canadian approach: GMR only! [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2009-02-08 01:44 (6351 d 08:10 ago) – Posting: # 3205
Views: 27,161

Dear D. Labes,

❝ ❝ Sometimes I forget the true country of the brave and the free - Canada...


❝ Brave and free already since a long time ago regarding their outstanding handling of Cmax :ok:.


Not to see the wood for the trees!

Though I quoted Eric correctly (the sentence is already given in Health Canada's Notice for Industry for rapid onset drugs from June 2005) I overlooked that nobody asks for a confidence interval. :-D
So only the mean should lie within 0.8-1.25.

Going back to my examples:
first post
Example 1: nonparametric tmax BE, parametric AUCReftmax BE
Example 2: nonparametric tmax not BE, parametric AUCReftmax not BE
second post
Example 3: nonparametric tmax not BE, parametric AUCReftmax BE (though close: GMR 81.2%)

I guess the 'Canadian way' would be an alternative for EMEA's 'statistical experts' not accepting dreadful nonparametrics - and dealing with high variability whilst not loosing their faces.
Hopefully somebody suggested it to EMEA; I realized it just today (one week too late) and suggested in my comments keeping the nonparametric method. :rotfl:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
330 visitors (0 registered, 330 guests [including 24 identified bots]).
Forum time: 10:54 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5